3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Myelodysplastic Syndromes
6
Hematologic Neoplasms
5
Lymphoma, Non-Hodgkin
4
Myeloproliferative Disorders
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hodgkin Disease
3
Bone Marrow Failure Disorders
3
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Anemia, Refractory, with Excess of Blasts
2
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Shwachman-Diamond Syndrome
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Recurrence
1
Rasmussen subacute encephalitis
1
Primary Myelofibrosis
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Opsoclonus-Myoclonus Syndrome
1
Non-Malignant Neoplasm
1
Neuromyelitis Optica
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Interventions
Nivolumab
3
Ipilimumab
3
poly ICLC
2
Specimen Handling
2
Sorafenib
2
Irinotecan
2
spartalizumab
1
sapanisertib
1
pembrolizumab
1
durvalumab
1
dostarlimab
1
dehydroftorafur
1
balstilimab
1
atezolizumab
1
aflibercept
1
Watchful Waiting
1
Vincristine
1
Surveys and Questionnaires
1
Platinum
1
Oxaliplatin
1
Observation
1
Gemcitabine
1
Fluorouracil
1
Etoposide
1
Doxorubicin
1
DT2216
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fibrolamellar hepatocellular carcinoma
×
Antilymphocyte Serum
×
1 year
×
Clear all
No trials found.